Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.

about

Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.

Item

http://www.wikidata.org/entity/Q47784937

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@en

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@nl

type

Item

label

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@en

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@nl

prefLabel

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@en

Organoruthenium Complexes with ...... by a New Mechanism of Action.

@nl

P1476

Organoruthenium Complexes with ...... t by a New Mechanism of Action

@en

P2093

Delia Bautista

http://www.w3.org/2001/XMLSchema#string

Gorakh Yellol

http://www.w3.org/2001/XMLSchema#string

Hana Kostrhunova

http://www.w3.org/2001/XMLSchema#string

Jana Kasparkova

http://www.w3.org/2001/XMLSchema#string

Jyoti Yellol

http://www.w3.org/2001/XMLSchema#string

Olga Stuchlikova

http://www.w3.org/2001/XMLSchema#string

Vojtech Novohradsky

http://www.w3.org/2001/XMLSchema#string

P2860

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects

Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin.

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.

Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase.

The resurgence of platinum-based cancer chemotherapy.

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes

Imidazole and benzimidazole derivatives as chemotherapeutic agents.

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Bioorganometallic chemistry--from teaching paradigms to medicinal applications.

P304

15294-15299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201703581

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

José Ruiz

Viktor Brabec

María Dolores Santana

P577

2017-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28922506

http://www.w3.org/2001/XMLSchema#string